TBC: Renal Impairment
Research payments
$811,897
Through program year 2021, $811,897 in research payments was reported against TBC: Renal Impairment, across 9 payments, paid by Eli Lilly and Company.
- Paid by
- Eli Lilly and Company
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $811,897 | 9 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Thomas Marbury Orlando, FL Named on 1 payment
- Joel Neutel Tustin, CA Named on 1 payment
- Kimberly Cruz Miami, FL Named on 1 payment
- Steve Sitar Anaheim, CA Named on 1 payment
- Margaret Chang Edgewater, FL Named on 1 payment
- Juan Carlos Rondon Hollywood, FL Named on 1 payment
- Eric Lawitz San Antonio, TX Named on 1 payment
- Stephen Harrison San Antonio, TX Named on 1 payment
- Zeid Kayali N Las Vegas, NV Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.